Red wine consumption not associated with reduced risk of colorectal cancer

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 849-855

  Chao, Chun ^a   Haque, Reina ^a   Caan, Bette J ^b   Poon, Kwun Yee T ^a   Tseng, Hung Fu ^a   Quinn, Virginia P ^a  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RED WINE; RISK REDUCTION;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; WINE;

ANIMALIA;

EID: 77955004680     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.492091     Document Type: Article

References (22)

1. Heinonen IM, Lehtonen PJ, and Hopia AI: Antioxidant activity of berry and fruit wines and liquors. J Agric Food Chem 46, 25-31, 1998.
2. Lugasi A and Hovari J: Antioxidant properties of commercial alcoholic and nonalcoholic beverages. Nahrung 47, 79-86, 2003.
3. Sato M, Suzuki Y, Okuda T, and Yokotsuka K: Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci Biotechnol Biochem 61, 1800-1805, 1997.
4. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, et al.: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224, 274-283, 2007.
5. Kundu JK and Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269, 243-261, 2008.
6. Sengottuvelan M, Viswanathan P, and Nalini N: Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27, 1038-1046, 2006.
7. Tessitore L, Davit A, Sarotto I, and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21, 1619-1622, 2000.
8. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, et al.: Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39, 102-107, 2001.
9. Anderson JC, Wiggins BJ, Alpern ZA, Martin CA, and Hubbard-Ells PM: Lifestyle or resveratrol? Comparison of white and red wine consumption and colorectal neoplasia. Presented at the American College of Gastroen- terology Annual Meeting, Las Vegas, Nevada. Abstract number 920, 2006.
10. Boffetta P and Hashibe M: Alcohol and cancer. Lancet Oncol 7, 149-156, 2006.
11. Perreira KM and Sloan FA: Excess alcohol consumption and health outcomes: a 6-year follow-up of men over age 50 from the health and retirement study. Addiction 97, 301-310, 2002.
12. Enger SM, Van Den Eeden SK, Sternfeld B, Loo RK, Quesenberry CP, Jr., et al. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health 6, 172, 2006.
13. Kristal AR., Patterson RE, Neuhouser ML, Thornquist M, Neumark- Sztainer D, et al. Olestra Postmarketing Surveillance Study: design and baseline results from the sentinel site. J Am Diet Assoc 98, 1290-1296, 1998.
14. Kristal AR, Stanford JL, Cohen JH, Wicklund K, and Patterson RE: Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8, 887-892, 1999.
15. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, et al. (1999) Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9, 178-187.
16. Haque R, Chiu V, Mehta KR, and Geiger AM: An automated data algorithm to distinguish screening and diagnostic colorectal cancer endoscopy exams. J Natl Cancer Inst Monogr 116-118, 2005.
17. Moskal A, Norat T, Ferrari P, and Riboli E: Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 120, 664-671, 2007.
18. Cho E, Smith-Warner SA, Ritz J, Van Den Brandt PA, Colditz GA, et al.: Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140, 603-613, 2004.
19. Klatsky AL: Invited commentary: never, or hardly ever? It could make a difference. Am J Epidemiol 168, 872-875, 2008.
20. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, et al.: Respond to "Never, or Hardly Ever?" Am J Epidemiol 168: 876-877, 2008.
21. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, et al.: Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol 168, 866-871, 2008.
22. Kaldas MI, Walle UK, and Walle T: Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 55, 307-312, 2003.